Progress in the study of intragastric occupancy device for weight reduction.
10.11817/j.issn.1672-7347.2023.220607
- Author:
Qianqian YU
1
;
Yaoquan CAO
2
;
Zeyang WANG
2
;
Ziyao CAO
2
;
Liyong ZHU
3
Author Information
1. Department of General Surgery, Third Xiangya Hosipital, Central South University, Changsha 410013. yuqianqian@csu.edu.cn.
2. Department of General Surgery, Third Xiangya Hosipital, Central South University, Changsha 410013.
3. Department of General Surgery, Third Xiangya Hosipital, Central South University, Changsha 410013. zly8128@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
intragastric balloons;
intragastric capsules;
intragastric space-occupying devices;
obesity;
weight reduction
- MeSH:
Humans;
Capsules;
Weight Loss;
Obesity/surgery*;
Overweight;
Stomach/surgery*
- From:
Journal of Central South University(Medical Sciences)
2023;48(4):614-620
- CountryChina
- Language:English
-
Abstract:
Obesity is a global public health problem that imposes a heavy economic burden on society. The current main strategies for treating obesity include lifestyle interventions, pharmacological treatments, endoscopic treatments and metabolic surgery. With the development of medical technology, weight reduction by intragastric occupancy devices represented by intragastric balloons and intragastric capsules are gradually emerging. Intragastric balloons are used to reduce weight by occupying the volume of the stomach with balloons filled with different volumes of gas or liquid, among which ReShape, Orbera, Obalon, Elipse and Spatz balloons are gradually used in patients with mild to moderate obesity due to their non-invasive, high safety and reusable advantages. Intragastric capsules are recommended in overweight and obese patients for weight loss through hydrogels with transient superabsorbent swelling properties and completely noninvasive. Both approaches achieve weight loss by limiting gastric volume, increasing satiety and reducing food intake. Despite the presence of adverse gastrointestinal events associated with nausea, vomiting, and abdominal distention, they offer new ideas for the non-invasive clinical treatment of obesity.
